You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
邁普醫學(301033.SZ):上半年淨利潤同比預增127.05%-177.51%
格隆匯 07-17 18:30

格隆匯7月17日丨邁普醫學(301033.SZ)公佈2024年半年度業績預吿,經財務部門初步測算,預計2024年半年度實現歸屬於上市公司股東的淨利潤盈利2,700.00萬元–3,300.00萬元,比上年同期增長127.05%-177.51%;扣除非經常性損益後的淨利潤盈利2,300.00萬元–2,800.00萬元,比上年同期增長144.23%-197.33%;營業收入11,900.00萬元–12,600.00萬元,比上年同期增長38.83%-47.00%。

業績變動原因説明:報吿期內,公司歸屬於上市公司股東的淨利潤及扣除非經常性損益後的淨利潤較去年同期上升,主要原因系公司圍繞年初制定的經營目標有序開展工作,隨着市場營銷力度的加大,公司2024年半年度主營業務收入穩步增長,盈利能力顯著提高導致業績相應增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account